EC approves expanded indication for Merck’s Pneumococcal 15-valent Conjugate Vaccine EP News Bureau Oct 27, 2022 The approval facilitates availability of Vaxneuvance for this population in all 27 European Union (EU) member states plus Iceland,…
CDC ACIP votes to provisionally recommend Merck’s Vaxneuvance in series with Pneumovax 23 EP News Bureau Oct 21, 2021 Series would be routinely recommended both for adults 65 years and older and for adults aged 19 to 64 at an increased risk for…
Merck gets US FDA nod of adult pneumococcal 15-valent conjugate vaccine EP News Bureau Jul 17, 2021 VAXNEUVANCE demonstrated non-inferior immune responses for the serotypes shared with PCV13 (1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C,…
